JORDAN ENGELMAN: Open Payments
NPI 1578988739 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 18 payments from 10 companies in 2025. Trend: 2023 $543 · 2024 $328 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $118 |
| PFIZER INC. | 5 | $86 |
| Lilly USA, LLC | 4 | $79 |
| Dexcom, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: Ozempic, MOUNJARO, ELIQUIS, NURTEC ODT, Dexcom G6 Transmitter, XYOSTED, FARXIGA, Xelstrym.
Industry payments across IL — which companies pay providers there.
